Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Statin treatment is associated with insulin sensitivity decrease in type 1 diabetes mellitus : a prospective, observational 56 month follow-up study (CROSBI ID 227699)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Duvnjak, Lea ; Blaslov, Kristina Statin treatment is associated with insulin sensitivity decrease in type 1 diabetes mellitus : a prospective, observational 56 month follow-up study // Journal of Clinical Lipidology, 10 (2016), 4; 1004-1010. doi: 10.1016/j.jacl.2016.04.012

Podaci o odgovornosti

Duvnjak, Lea ; Blaslov, Kristina

engleski

Statin treatment is associated with insulin sensitivity decrease in type 1 diabetes mellitus : a prospective, observational 56 month follow-up study

Objective: Statins are effective in the primary and secondary prevention of cardiovascular events in individuals with and without diabetes mellitus. Emerging evidence, however, suggest that statins might reduce insulin sensitivity and secretion in healthy population as well as in type 2 diabetes. We wanted to investigate the effect of statin therapy introduction on insulin sensitivity in type 1 diabetes mellitus (T1DM) patients. Methods: This prospective observational 56 months long study included 832 randomly selected T1DM patients aged 25-61 years. Uncontrolled dyslipidemia and clinician perceived need for treatment, rather than randomization, was basis for individuals being started on either atorvastatin or simvastatin (10-40 mg) ; N=345, 41.47%. Patients on statin treatment were compared to those unexposed to statin. Insulin sensitivity was accessed using equation derived from euglycemic- hyperinsulinemic clamp studies estimated glucose disposal rate (eGDR). Results: Patients who started statin therapy (59.42% atorvastatin and 40.58% simvastatin) experienced a greater decrease in insulin sensitivity (19.27 % vs 12.82 % p<0.001) as well as metabolic control deterioration compared to statin free group. The risk of decrease in insulin sensitivity attributable to statin use was 36.7% (HR 1.36 (95% CI 1.31, 1.43) after adjustment for age, gender, disease duration, smoking status and the concomitant antihypertensive therapy. Conclusion: Although there is still a lack of a clear molecular explanation on the adverse effects of statin therapy on insulin sensitivity, we showed that it deteriorates insulin sensitivity and metabolic control in type 1 DM. The cardiovascular benefits of statin treatment might outweigh the risk of developing insulin resistance, but the possible metabolic control worsening merits to be considered.

type 1 diabetes mellitus ; inuslin sensitivity ; statins

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

10 (4)

2016.

1004-1010

objavljeno

1933-2874

10.1016/j.jacl.2016.04.012

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost